The first-ever conference to highlight women on the forefront of medical innovation, MedtechVision brought together business leaders, inventors, investors, physicians and policymakers for an interactive discussion of real-world solutions to the most challenging issues facing our industry.
Thursday, September 15 and Friday, September 16, 2011
Rosewood Sand Hill, Menlo Park, Calif.
- Kickoff Keynote – Patients are More Than a P-value: The Path Forward From the Patient Perspective: Bray Patrick-Lake, president and CEO of the PFO Research Foundation
- Industry Keynote – Continuing to Innovate in Today’s Economic and Regulatory Environment: Ginger Graham, former president and CEO, Amylin Pharmaceuticals, and former group chairman, Office of the President, Guidant Corporation
- Provider Keynote –Bringing it All Together: Clinical Practice, Industry, Research & Education: Ellen Zane, president and CEO Tufts Medical Center
THURSDAY – SEPTEMBER 15, 2011
7:30 – 8:30 AM
Introduction & Welcome
8:30 – 8:45 AM
Kickoff Keynote Speaker
Bray Patrick-Lake – President and CEO of the PFO Research Foundation
8:45 – 9:45 AM
Physician Panel – Defining and Addressing the Need
9:45 – 10:45 AM
Accurately identifying a “true unmet clinical need” is the leading edge component of medtech innovation and, arguably, the ultimate driver of broad clinical adoption. This panel will explore today’s definition of that phrase in the context of physician roles in the product development process, industry-provider relationships, and the integration of new technologies into daily practice.
- Moderator: Nancy Lynch, MD – Orthopedic surgeon, Independent Orthopedic Technologies Consultant
- Francine Kaufman, MD – Pediatric endocrinologist, Children’s Hospital of Los Angeles; Former President, American Diabetes Association; Chief Medical Officer and VP, Global Medical, Clinical and Health Affairs, Medtronic Diabetes
- Donna Pacicca, MD – Orthopedic surgeon, Children’s Mercy Hospital, Kansas, MO
- Shyamali Singhal, MD, PhD, Surgical Oncologist and Medical Director, Cancer Center at
El Camino Hospital
- Bonnie Weiner, MD – Professor of Medicine, University of MA Medical School; Director Cardiovascular Medicine Fellowship Program, St Vincent Hospital; Board Chair, Chief Medical Officer Accreditation for Cardiovascular Excellence; Former President, Society for Cardiovascular Angiography and Interventions
10:45 – 11:00 AM
Investment in Medtech Panel – Where Do We Go from Here?
11:00 – 12:00 PM
The cost of innovation has significantly increased and the returns on that investment have been severely impacted. This panel will explore whether this is just a cycle, or whether and what new models of investing are needed that might change this pattern. Where will growth come from over the next decade that will help fuel innovation and hopefully create returns that will continue to drive investment?
- Moderator: Tamara Elias, MD – Principal, Essex Woodlands
- Amy Wendell – Senior VP Strategy and Business Development, Covidien
- Susan E. Morano – World Wide VP of New Business Development, Johnson & Johnson Medical Devices & Diagnostics Group
- Beckie Robertson – Managing Director ,Versant Ventures
- Mercy Forde – Senior Relationship Manager, Venture Capital & Private Equity Services,
Silicon Valley Bank
- Ashley Ledbetter Dombkowski, Ph.D. – Chief Business Officer, 23andMe
Lunch & CEO Roundtable – The New Face of Leadership
12:00 – 1:30 PM
The medtech landscape is changing both in terms of who is leading the companies and what competencies CEOs and their teams must have to be successful. This panel will address what’s changed, the new competencies that are needed and new opportunities that have emerged while exploring any differences specific to being a female CEO and how to address and even capitalize on those differences.
- Moderator: Sandra J Miller – Director, Kauffman Labs for Enterprise Creation
- K. Angela Macfarlane – President and CEO, ForSight Labs
- Beverly Huss – President and CEO, Vibrynt
- Lisa Earnhardt – President and CEO, Intersect ENT
- Ferolyn Powell – DVP & GM, Abbott Vascular Structural Heart (formerly CEO of Evalve, Inc)
New Clinical Opportunities Panel – Health of Women, Not Just Women’s Health
1:30 – 2:30 PM
Despite the fact that there are critical biological differences between men and women, clinical research often treats women no differently than men. Diseases that differently or disproportionately affect women represent a great opportunity for innovation and advancement in care. This panel will explore a few clinical areas where women are different from men and how diagnosis and treatment can be tailored to these differences.
- Moderator: Alexandra Lansky, MD – Director of Yale Cardiovascular Research Group
- Lisa M. Tate – CEO, WomenHeart: The National Coalition for Women with Heart Disease
- Lynn Westphal, MD – Director of Women’s Health at Stanford University
- Ellen Goldberg – Marketing Strategy Consultant;
former Vice President, Marketing, Crescendo Bioscience
- Deborah Kilpatrick – Senior Vice President, Commercial, CardioDx
- Marie Barry – Industry Consultant, Biotechnology and Pharmaceuticals
- Vibeke Strand, MD, FACP, FACR – Adjunct Clinical Professor in the Division of Immunology and Rheumatology, Stanford University School of Medicine
Reimbursement Case Study Panel – Getting Good Innovation Paid For
Without Breaking the Bank
2:30 – 3:30 PM
It’s not news that obtaining reimbursement for innovative technology has become increasingly challenging and costly. This panel will provide insight into the needs and challenges of the payors, the kinds of innovation will be rewarded (and which will not) and real world strategies to effectively bridge the gap between the needs of the payors and the limitations of the innovators.
- Moderator: Anne Abreu – Director of Reimbursement, Sonitus Medical
- Liesl Cooper – VP Healthcare Economics, Policy and Reimbursement, Covidien
- Betsy Thompson, MD, DrPH – Chief Medical Officer, CMS Region IX
- Robin G. Cisneros – National Director, Medical Technology Assessment and Products, The Permanente Federation
3:30 – 3:45 PM
Healthcare Costs and Innovation Panel – Friends or Foes?
3:45 – 4:45 PM
“Bending the cost curve” is an often used phrase and medical technology has been a presumed cost creator. The question for this panel is whether there is room for both cost containment and medical advancement or, alternatively, whether technology could even be a solution to the rising healthcare costs. If so, what are the incentives, disincentives and innovative programs currently being created.
- Moderator: Lisa Suennen – Managing Member, Psilos Group Managers
- Deneen Vojta, MD – Senior VP of the UnitedHealth Center for Health Reform and Modernization
- Molly Joel Coye, MD, MPH – Chief Innovation Officer, UCLA Health System, University of California, Los Angeles
- Michelle Heying – President and COO, DynaVox Technologies
4:45 – 5:00 PM
5:30 – 6:30 PM
Dinner & Industry Keynote Speaker
6:30 – 9:00 PM
FRIDAY – SEPTEMBER 16, 2011
7:00 – 8:00 AM
Agenda for the day
8:00 – 8:15 AM
Provider Keynote Speaker
8:15 – 9:00 AM
Emerging Markets Panel – New Frontier of Growth
9:00 – 10:00 AM
Emerging markets are the next frontier of growth for many industries, including Healthcare. However these markets also represent complex business environments with many dynamics that must be considered and addressed for success. This panel will focus on China, one of the largest emerging markets, and explore the opportunities for growth, challenges and key considerations, such as intellectual property, and provide the perspective of both a large multi-national company and a local Chinese company doing business in this market.
- Moderator: Lisa Greenwald-Swire, JD – Principal, Fish & Richardson
- Nancy Travis – Vice President Global Strategy Advamed, former Deputy Director of US State Dept Office of Economic Policy in the Bureau of Easter Asia and Pacific Affairs
- Wendy X. Shao – Managing Director & Chairman of Board of R&D Systems China Co. Ltd.
10:00 – 10:15 AM
Regulatory Panel – Panels, Pivotals and Pain
10:15 – 11:15 AM
The changing regulatory environment is one of the most discussed and rigorously debated areas of medtech. Regulation is often cited as a barrier to timely progress to market while consistent regulatory pathways are essential to attracting investors. This panel will address how do we remove unnecessary barriers and make the process more predictable while maintaining the appropriately assuring safety. The discussion will center around what goes wrong, what goes right, what can be done differently, and what we need to know to be successful in the future.
- Moderator: Natasha Leskovesk, RN, JD – Partner, Cooley LLP, former researcher, NIH
- Debra J. Rasmussen – Senior Director Regulatory Affairs, Companion Diagnostic CoE,
Johnson & Johnson
- Jonette Foy, Ph.D. – Acting Deputy Director for Science & Regulatory Policy, Office of Device Evaluation, CDRH
- Elaine Tseng, JD – Partner King & Spalding LLP, former FDA Counsel
- Cindy Domecus, RAC (US & EU) – Principal, Domecus Consulting Services LLC
Entrepreneurship Panel – Starting and Building Successful Companies
in the New World Order
11:15 – 12:15 PM
There is no secret recipe for founding and building medtech companies. Groundbreaking ideas are as unique as the strategy and tactics required to turn them into successful businesses. Collecting examples of how others have navigated through diverse circumstances is key. Seasoned entrepreneurs will share the complexities of companies they’ve founded, how they’ve approached challenges, and what creative solutions they’ve employed to succeed.
- Moderator: Tamara Fraizer, JD, PhD – Principal, Fish & Richardson
- Stacy Enxing Seng – President, ev3/Covidien Peripheral Vascular
- Denise Zarins – Co-Founder, Ardian/Medtronic
- Karen Talmadge, PhD – Co-Founder of Kyphon and former start-up CEO
- Erica Rogers – COO, Medicines360 and co-founder of Visiogen
Lunch and Conclusion
12:15 – 1:00 PM